Market Overview

4 Stocks Moving In Monday's After-Hours Session

Related OMED
When Larger Firms Walk Away From Partnerships With Smaller Ones: How Bad Is The Damage?
The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan
Related ACHN
The Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen
The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial
Achillion Pharmaceuticals Expands Operations and Clinical Development into Philadelphia Area ... (GuruFocus)


  • Oncomed Pharmaceuticals Inc (NASDAQ: OMED) shares are up 18 percent after a 13D filing shows Mereo BioPharma Group PLC holds a 10.7 percent stake in the company.
  • Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) shares are up 5 percent after reporting interim data for ACH-4471 Phase 2 trials and provided clinical development strategy update. The company expects 2019 cash burn of $80 million-$85 million. Achillion expects a year-end 2018 cash and marketable securities balance of around $270 million.
  • Boeing Co (NYSE: BA) shares are up 1 percent after raising its buyback from $18 billion to $20 billion. The company also raised its quarterly dividend from $1.71 to $2.055 per share. Earlier in the day, Boeing announced it acquired 80 percent of Embraer for $4.2 billion.
  • Oracle Corporation (NYSE: ORCL) shares are up 1 percent after reporting a second-quarter earnings beat. Earnings came in at 80 cents per share, beating estimates by 2 cents. Sales came in at $9.562 billion, beating estimates by $32 million.

Posted-In: News After-Hours Center Movers Trading Ideas


Related Articles (ACHN + BA)

View Comments and Join the Discussion!

Economic Data Scheduled For Tuesday

Back to Basics: Laurel Alterman and William A. Gibson v. Commissioner of Internal Revenue